Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis

被引:55
作者
Cavalcante, IC
Castro, MV
Barreto, ARF
Sullivan, GW
Vale, M
Almeida, PRC
Linden, J
Rieger, JM
Cunha, FQ
Guerrant, RL
Ribeiro, RA
Brito, GAC
机构
[1] Univ Fed Ceara, Dept Morfol, Fac Med, BR-60416030 Fortaleza, Ceara, Brazil
[2] Univ Virginia, Charlottesville, VA 22903 USA
[3] Adenosine Therapeut LLC, Charlottesville, VA USA
[4] Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, Brazil
关键词
D O I
10.1128/IAI.74.5.2606-2612.2006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Clostridium difficile is a spore-forming, anaerobic, gram-positive bacillus that releases two main virulence factors: toxins A and B. Toxin A plays an important pathogenic role in antibiotic-induced diarrhea and pseudomembranous colitis, a condition characterized by intense mucosal inflammation and secretion. Agonist activity at A(2A) adenosine receptors attenuates inflammation and damage in many tissues. This study evaluated the effects of a new selective A(2A) adenosine receptor agonist (ATL 313) on toxin A-induced injury in murine ileal loops. ATL 313 (0.5 to 5 nM) and/or the A(2A) adenosine receptor antagonist (ZM241385; 5 nM) or phosphate-buffered saline (PBS) were injected into ileal loops immediately prior to challenge with toxin A (I to 10 mu g/loop) or PBS. Intestinal fluid volume/length and weight/length ratios were calculated 3 h later. heal tissues were collected for the measurement of myeloperoxidase, adenosine deaminase activity, tumor necrosis factor alpha (TNT-a) production, histopathology, and detection of cell death by the TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling) method. Toxin A significantly increased volume/length and weight/length ratios in a dose-dependent fashion. ATL 313 treatment significantly (P < 0.05) reduced toxin A-induced secretion and edema, prevented mucosal disruption, and neutrophil infiltration as measured by myeloperoxidase activity. ATL 313 also reduced the toxin A-induced TNF-alpha production and adenosine deaminase activity and prevented toxin A-induced cell death. These protective effects of ATL 313 were reversed by ZM241385. In conclusion, the A(2A) adenosine receptor agonist, ATL 313, reduces tissue injury and inflammation in mice with toxin A-induced enteritis. The finding of increased ileal adenosine deaminase activity following the administration of toxin A is new and might contribute to the pathogenesis of the toxin A-induced enteritis by deaminating endogenous adenosine.
引用
收藏
页码:2606 / 2612
页数:7
相关论文
共 46 条
[1]   Antibiotic-associated diarrhea [J].
Bartlett, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (05) :334-339
[2]  
Bayer E A, 1980, Methods Biochem Anal, V26, P1
[3]   Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells [J].
Bouma, MG ;
VandenWildenberg, FAJM ;
Buurman, WA .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1996, 270 (02) :C522-C529
[4]   Clostridium difficile toxin A induces intestinal epithelial cell apoptosis and damage:: Role of Gln and Ala-Gln in toxin A effects [J].
Brito, GAC ;
Carneiro, B ;
Oriá, RB ;
Destura, RV ;
Lima, AAM ;
Guerrant, RL .
DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (07) :1271-1278
[5]   Mechanism of Clostridium difficile toxin A-induced apoptosis in T84 cells [J].
Brito, GAC ;
Fujji, J ;
Carneiro, BA ;
Lima, AAM ;
Obrig, T ;
Guerrant, RL .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (10) :1438-1447
[6]   Clostridium difficile toxin A alters in vitro-adherent neutrophil morphology and function [J].
Brito, GAC ;
Sullivan, GW ;
Ciesla, WP ;
Carper, HT ;
Mandell, GL ;
Guerrant, RL .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (09) :1297-1306
[7]  
Calderón GM, 1998, INFECT IMMUN, V66, P2755
[8]   Neurokinin-1 (NK-1) receptor is required in Clostridium difficile-induced enteritis [J].
Castagliuolo, I ;
Riegler, M ;
Pasha, A ;
Nikulasson, S ;
Lu, B ;
Gerard, C ;
Gerard, NP ;
Pothoulakis, C .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1547-1550
[9]  
Cristalli G, 2001, MED RES REV, V21, P105, DOI 10.1002/1098-1128(200103)21:2<105::AID-MED1002>3.0.CO
[10]  
2-U